How Early Flu Exposure Can Shape a Child’s Lifelong Immunity
For many parents, a child’s first bout with the flu is a rite of passage: fever, runny nose, and a few days spent recovering at home. However, a new study reveals that this initial encounter with the influenza virus can have a lasting impact on a child’s immune system, influencing how their body responds to future infections.
Immune Imprinting: The First Flu’s Lasting Legacy
Researchers at Weill Cornell Medicine have discovered that early exposure to one strain of the flu can actually weaken a child’s ability to generate an effective antibody response against subsequent, different strains. This phenomenon, known as “immune imprinting,” was first described in 1960 but has been challenging to investigate until recently. The study, published in Nature, analyzed the immune responses of children exposed to influenza A viruses H3N2 and H1N1.
How Immune Imprinting Works
Immune imprinting occurs when the initial exposure to a virus creates a bias in the immune response, potentially hindering the body’s ability to effectively combat closely related viruses in the future. The study found that after initial exposure to H3N2, the antibodies produced were less effective at neutralizing H1N1 strains. This is due to a key site on the viral antigen being similar between the two subtypes, causing the initial immune response to H3N2 to inadvertently hinder the adaptation to H1N1.
The Role of Antibodies and B Cells
A first exposure to a virus triggers an initial immune response involving B cells, which produce antibodies and create a pool of memory B cells. These memory cells are designed to rapidly produce antibodies upon re-exposure to the same virus. However, when a related virus triggers this memory response, it can create a surge of antibodies that may not effectively neutralize the new threat and could even impede the development of a robust new response. This problem is particularly pronounced with initial exposures in early childhood.
Vaccination as a Potential Solution
The research suggests that simultaneous vaccination against both H3N2 and H1N1 could mitigate the negative effects of immune imprinting. B cells from infants vaccinated simultaneously against both strains showed no signs of this harmful imprinting effect.
What the Study Found
- Participants who encountered the two flu subtypes sequentially developed “cross-reactive” antibodies, but these antibodies were more effective against H3N2 than H1N1.
- H3N2-imprinted antibodies were ineffective against older strains of H1N1, potentially posing a future threat.
- Cryo-electron microscopy analysis revealed that a single amino acid difference in the stem region of H1N1 strains could significantly reduce antibody activity.
Implications for Future Vaccine Design
“These findings are a reminder that the effectiveness of a vaccine against a certain virus can be affected due to prior exposure to a related virus, which can make vaccine design very difficult,” said Dr. Patrick Wilson, Professor of Pediatric Research at Weill Cornell Medicine. The study highlights the importance of considering prior exposure when designing influenza vaccines, particularly for young children.
Flu Season Update – Europe and Spain (2025-2026)
Influenza is currently surging across Europe, with a new strain, A(H3N2) subclade K, driving infections. The World Health Organization reports that at least 27 of 38 countries in the European Region are experiencing high or very high influenza activity, and the season began roughly four weeks earlier than usual. In Spain, the flu season also started earlier than usual, with incidence rates exceeding epidemic thresholds.
Protecting Yourself and Your Family
Vaccination remains the most important step to avoid severe health outcomes from influenza. The current seasonal influenza vaccine has been shown to lower the risk of severe illness from the A(H3N2) influenza virus. Other preventative measures include practicing good hygiene, such as frequent handwashing, and considering wearing masks in crowded spaces, particularly for those at higher risk, including older adults, individuals with underlying conditions, pregnant women, and children.
Related reading